Cytek Biosciences, Inc. has grown revenue 308% a year over three years and 209% a year over five. Revenue growth, 3-year annual rate: +308% (Medical Devices median +12%). Revenue growth, 5-year rate: +209%, growth has picked up over the last three years. Years of annual history on file: 6, FY2020 to FY2025, as filed.

CTKBCytek Biosciences, Inc.

Healthcare

$5.37+42% 1Y

$5.37

$3.3652 weeks$6.09

Is it growing?

Watch

Operating margin narrowing (−9.1 points). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Margin direction−9.1 points operatingSEC EDGAR · Jun 30, 2026

Trailing-twelve-month operating margin, -23.0% now against -14.0% a year earlier.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CTKB growing?

Cytek Biosciences, Inc. has grown revenue 308% a year over three years and 209% a year over five.

+308%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +209%
Revenue growth, 5-year rate · +308% over three · growth has picked up over the last three years
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›